openPR Logo
Press release

United States Neurological Implants Market Trends: Innovative Devices Reshaping Neuroscience

10-07-2025 01:28 PM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Neurological Implants Market

Neurological Implants Market

DataM Intelligence unveils its latest report on the "Neurological Implants Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies aiming to stay ahead in the competitive Market.

Over 80% of deaths and health loss from neurological disorders occur in low- and middle-income countries, where access to neurological professionals is up to 70 times lower than in high-income regions, driving demand for neurological implants. Key players are focusing on innovative studies and product launches to expand the market. For example, Mint Neurotechnologies launched the "EXPLORE" project with a £100,000 grant to extend its neural sensing technology beyond drug-resistant epilepsy. Similarly, Neuralink initiated a feasibility study for a brain-computer interface enabling thought-controlled robotic arms, further fueling market growth.

According to HOSPIDIO News (2024), deep brain stimulation (DBS) surgery in India costs around $20,000-$28,000 (₹16.5-23 lakh), varying by device type and features. In high-income countries like the U.S., the procedure ranges from $35,000 to $100,000, making India a more affordable option.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/neurological-implants-market?kb

List of Top Key Player:

Medtronic, Boston Scientific Corporation, NeuroPace Inc., Abbott Laboratories, Aleva Neurotherapeutics, Renishaw PLC, NEVRO CORP., Synapse Biomedical Inc., and LivaNova PLC among others.

Industry Developments:

In January 2024, Medtronic plc announced FDA approval for its Percept RC Deep Brain Stimulation (DBS) system. This rechargeable neurostimulator expands the Medtronic Percept family, which also features the Percept PC neurostimulator, BrainSense technology, and SenSight directional leads.

The rising prevalence of neurological disorders is driving demand for advanced neural implants. In the U.S., Alzheimer's cases are projected to grow from 5.8 million to 14.3 million by 2060, while over 11 million individuals are affected by movement disorders and 3.4 million live with epilepsy. China leads the G20 with the highest incidence and prevalence of Parkinson's disease, with rates rising dramatically over the past decades.

Innovations in deep brain stimulation (DBS) are transforming treatment, offering customizable therapies for Parkinson's, essential tremor, dystonia, and epilepsy. Notable developments include $8 million in funding for soft neural implants, motor cortex-driven DBS research, and Medtronic's NeuroSmart Portable MER Navigation System in India, enhancing precision and effectiveness of DBS procedures.

Forecast Projection:

The Global Neurological Implants Market is poised for significant growth between 2025 and 2032. In 2024, the market maintained a steady upward trajectory, and with strategic initiatives by leading players accelerating adoption, the market is expected to soar throughout the forecast period. Companies leveraging these trends are well-positioned to capture emerging opportunities and maximize revenue potential.

Market Intelligence Research Process:

The Neurological Implants Market research report by DataM Intelligence combines primary and secondary data to deliver deep, actionable insights. It examines the full spectrum of factors shaping the industry, from government regulations and market conditions to competitive dynamics, historical trends, technological breakthroughs, upcoming innovations, and potential challenges. This comprehensive analysis not only highlights growth prospects but also identifies barriers, equipping businesses to navigate market volatility and capitalize on emerging opportunities.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=neurological-implants-market

Key Segmentation:

Product Type: Deep Brain Stimulators | Vagus Nerve Stimulators | Spinal Cord Stimulators

Material: Silicon | Tungsten | Platinum-iridium | Nanotubes | Others

Application: Chronic Pain | Parkinson's Disease | Epilepsy | Depression | Essential Tremor | Alzheimer's Disease

End-User: Hospitals | Neurology Clinics | Others

Global Growth Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1 - Market Overview: Kickstarts the report with a comprehensive snapshot of the Neurological Implants Market, summarizing key segments by region, product type, and application. Highlights include market size, segment growth potential, and short- & long-term industry outlook.

Chapter 2 - Emerging Trends: Uncovers the game-changing trends and high-impact innovations shaping the future of the industry.

Chapter 3 - Competitive Landscape: Offers a deep dive into market competition, detailing revenue shares, strategic initiatives, and recent mergers & acquisitions.

Chapter 4 - Top Player Profiles: Features detailed company profiles, covering revenue, profit margins, product lines, and major milestones for leading market players.

Chapters 5 & 6 - Regional & Country Analysis: Breaks down revenue performance across global regions, providing insights on market sizes, opportunities, and growth prospects worldwide.

Chapter 7 - Segmentation Analysis: Explores market segmentation by type, revealing high-potential categories and guiding businesses towards lucrative areas.

Chapter 8 - Application Insights: Examines downstream markets and identifies promising sectors for expansion, showing how different applications are driving growth.

Chapter 9 - Supply Chain Mapping: Maps the entire industry supply chain, highlighting upstream and downstream activities for a holistic market perspective.

Chapter 10 - Key Takeaways: Concludes with critical insights and actionable strategies, equipping stakeholders to make informed decisions and stay ahead in the market.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/neurological-implants-market?kb

FAQ's

Q1: What is the current size of the Neurological Implants Market and its future potential?

A: The Neurological Implants Market was valued at US$ 5.88 billion in 2023 and is projected to surge to US$ 12.39 billion by 2031

Q2: How fast is the Neurological Implants Market expected to grow in the coming years?

A: The market is forecast to expand at a robust CAGR of 9.8 % between 2025 and 2032, signaling strong global growth and investment potential.

Q3: Which regions are dominating the Neurological Implants Market and which are fastest-growing?

A: North America dominating the Neurological Implants market.

Request 2 Days Free Trials with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?kb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release United States Neurological Implants Market Trends: Innovative Devices Reshaping Neuroscience here

News-ID: 4211898 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

United States Polymyositis Drugs Market to hit US$132.6 Million By 2031 | Leading Companies - Pfizer Inc., Aspen API, LGM Pharma, Tecoland Corporation
United States Polymyositis Drugs Market to hit US$132.6 Million By 2031 | Leadin …
Market Size and Forecast: The global Polymyositis drugs market reached US$ 103.1 million in 2023 and is expected to reach US$ 132.6 million by 2031 growing with a CAGR of 3.2% during the forecast period 2024-2031. The Polymyositis Drugs Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions
United States Cancer Immunotherapy Industry Forecast Report: High-Impact Therapies & Global Industry Trends
United States Cancer Immunotherapy Industry Forecast Report: High-Impact Therapi …
Cancer Immunotherapy Market reached from US$ 118.63billion in 2022 to US$ 126.93 billion in 2023. Growth US$ 137.70 billion in 2024 and is expected to reach US$ 261.74 billion by 2033, growing at a CAGR of 7.9% during the forecast period 2025-2033. DataM Intelligence unveils its latest report on the "Cancer Immunotherapy Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study
United States Bifidobacterium Probiotics Market to hit US$1.9 Billion By 2031 | Major Keyplayers - DuPont, Goerlich Pharma GmbH, Mitushi Bio Pharma, Chr. Hansen Holding A/S
United States Bifidobacterium Probiotics Market to hit US$1.9 Billion By 2031 | …
Market Size and Forecast: Global Bifidobacterium Probiotic Market reached US$ 1.1 billion in 2023 and is expected to reach US$ 1.9 billion by 2031, growing with a CAGR of 8.8% during the forecast period 2024-2031. The Bifidobacterium Probiotic Market Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions
United States Intumescent Coatings Industry 2025: Growth, Trends & Key Players Analysis
United States Intumescent Coatings Industry 2025: Growth, Trends & Key Players A …
DataM Intelligence unveils its latest report on the "Intumescent Coatings Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies aiming

All 5 Releases


More Releases for Neurological

Major Growth Driver Identified in 2025 Neurological Biomarkers Market: Rising Pr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Neurological Biomarkers Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size of neurological biomarkers has seen a swift augmentation in the past few years. Projected to escalate from $10.7 billion in 2024 to $11.96 billion in 2025, it holds a compound annual growth
Neurological Biomarkers Market : An Overview
Introduction: Neurological biomarkers are biological markers that provide insight into the physiological, pathological, and pharmacological responses of the nervous system. These biomarkers play a critical role in diagnosing, monitoring, and treating neurological disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and epilepsy. With growing advancements in genomics, proteomics, and molecular biology, neurological biomarkers have emerged as essential tools in precision medicine, allowing for early detection and personalized treatment plans for
Neurological Biomarkers Market: An Overview
Introduction: Neurological biomarkers refer to measurable indicators that can be used to detect or monitor neurological diseases or disorders. These biomarkers provide critical insights into the diagnosis, progression, and treatment of neurological conditions such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and traumatic brain injury. Neurological biomarkers are typically measured in bodily fluids like cerebrospinal fluid (CSF), blood, or even imaging techniques like MRI. With advancements in molecular biology, genomics, and
Nurturing Neurological Wellness: Insights into the Global Neurological Disorder …
𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧: Neurological disorders represent a significant healthcare challenge, affecting millions worldwide and encompassing a diverse spectrum of conditions such as Alzheimer's disease, Parkinson's disease, epilepsy, and multiple sclerosis, among others. In the quest for effective management and treatment, pharmaceutical interventions play a pivotal role. As we embark on a journey to explore the global neurological disorder drugs market, we unravel the complex interplay of resin types, applications, technologies, end-use industries, and
Neurological Biomarkers Market - Decoding Brain Health: Biomarkers Revolutionizi …
Newark, New Castle, USA: The "Neurological Biomarkers Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Neurological Biomarkers Market: https://www.growthplusreports.com/report/neurological-biomarkers-market/8040 This latest report researches the industry structure, sales, revenue,
Neurological Disorder Drugs Market - Advancing Neurological Health through Innov …
Newark, New Castle, USA - new report, titled Neurological Disorder Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Neurological Disorder Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Neurological Disorder Drugs market. The report offers an overview of